IL86417A - Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers - Google Patents

Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers

Info

Publication number
IL86417A
IL86417A IL86417A IL8641788A IL86417A IL 86417 A IL86417 A IL 86417A IL 86417 A IL86417 A IL 86417A IL 8641788 A IL8641788 A IL 8641788A IL 86417 A IL86417 A IL 86417A
Authority
IL
Israel
Prior art keywords
aqueous solution
biological
mixing
stabilizers
pathogens
Prior art date
Application number
IL86417A
Other languages
English (en)
Other versions
IL86417A0 (en
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of IL86417A0 publication Critical patent/IL86417A0/xx
Publication of IL86417A publication Critical patent/IL86417A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL86417A 1987-05-22 1988-05-18 Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers IL86417A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5292687A 1987-05-22 1987-05-22

Publications (2)

Publication Number Publication Date
IL86417A0 IL86417A0 (en) 1988-11-15
IL86417A true IL86417A (en) 1992-09-06

Family

ID=21980809

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86417A IL86417A (en) 1987-05-22 1988-05-18 Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers

Country Status (11)

Country Link
EP (1) EP0292003B1 (ja)
JP (2) JP2605102B2 (ja)
AT (1) ATE103185T1 (ja)
AU (1) AU606159B2 (ja)
CA (1) CA1337688C (ja)
DE (1) DE3888571T2 (ja)
ES (1) ES2061554T3 (ja)
FI (1) FI95778C (ja)
IL (1) IL86417A (ja)
NO (1) NO176234C (ja)
NZ (1) NZ224740A (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
DE60035260T2 (de) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington Neue albuminfreie faktor viii formulierungen
WO2006131515A2 (en) * 2005-06-06 2006-12-14 Novo Nordisk A/S Stabilised il-21 compositions
DE102006008613A1 (de) 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
CA1213827A (en) * 1983-04-29 1986-11-12 Ricardo H. Landaburu Process for pasteurizing fibronectin
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61189228A (ja) * 1985-02-19 1986-08-22 Nippon Sekijiyuujishiya 血液凝固第８因子製剤の製法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
JPS6289628A (ja) * 1985-09-11 1987-04-24 Green Cross Corp:The 人フイブリノゲン製剤の加熱処理法
JPS6281327A (ja) * 1985-10-04 1987-04-14 Green Cross Corp:The 人トロンビン製剤の加熱処理方法

Also Published As

Publication number Publication date
IL86417A0 (en) 1988-11-15
NO882242D0 (no) 1988-05-20
JP2605102B2 (ja) 1997-04-30
JPS649937A (en) 1989-01-13
JPH09118634A (ja) 1997-05-06
NO176234B (no) 1994-11-21
ES2061554T3 (es) 1994-12-16
AU1664288A (en) 1988-11-24
FI95778C (fi) 1996-03-25
DE3888571T2 (de) 1994-08-11
EP0292003A2 (en) 1988-11-23
ATE103185T1 (de) 1994-04-15
JP2879427B2 (ja) 1999-04-05
FI882387A (fi) 1988-11-23
NO882242L (no) 1988-11-23
FI95778B (fi) 1995-12-15
EP0292003A3 (en) 1990-06-13
EP0292003B1 (en) 1994-03-23
DE3888571D1 (de) 1994-04-28
FI882387A0 (fi) 1988-05-20
CA1337688C (en) 1995-12-05
NZ224740A (en) 1990-01-29
AU606159B2 (en) 1991-01-31
NO176234C (no) 1995-03-01

Similar Documents

Publication Publication Date Title
IL86417A (en) Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
AU2118488A (en) Improvements in or relating to methods of treating damaged skin
AU5268279A (en) Isolation of membrane proteins from neisseria meningitidis and vaccines containing same
HUT44793A (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
DE69432351D1 (de) Verfahren zum sterilisieren von produkten
EP0237836A3 (en) Sterilization method
HUT47220A (en) Process for production of parenteralic compositions with slow-down effect
SE8803071D0 (sv) Bakteriebehandling for att bevara hokvalitet genom att tillegga genius bacillus mikroorganismer
ATE143054T1 (de) Verfahren zum abtrennen von lysine in form von einer wässerigen lösung und verwendung dieser lösung in der tierernährung
EP0309787A3 (en) Process for producing a highly purified, virus-free and biologically active transferrin preparation
AU647480B2 (en) Method for preparing a transparent adjusted milk whey protein and an adjusted milk whey protein product
JPS6452726A (en) Method for removing endotoxin of pertussis, pertussis toxoid and production thereof
BR8806020A (pt) Processo para produzir massas de celulas pro-embrionicas de algodao,para produzir embrioes maduros de algodao,para produzir plantulas e para produzir plantas de algodao e suspensao liquida de embrioes de algodao
HUT47375A (en) Fungicide compositions containing /2-cyano-2-oximino-acetyl/-aminoacid derivatives as active components and process for producing the active components
AU598945B2 (en) Process for the inactivation of recombinant dna
GR3017807T3 (en) Method for inactivating biological activity of DNA.
AU617052B2 (en) A process for the decontamination of cell cultures containing mycoplasmas
ES8608892A1 (es) Procedimiento para esterilizar materiales de envasado para el envasado aseptico de zumo de frutas y de vino
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
JPS6480286A (en) Method for purifying enzyme
JPS6463323A (en) Magnetizing treatment
JPS5668390A (en) Cultivation of yeast
SE8700136D0 (sv) Forfarande for behandling av amfotera aminosyror
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя
MA20183A1 (fr) Procede de valorisation de l'uranium,des terres rares et de l'ytterium contenus dans l'acide phosphorique

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired